Weekly subcutaneous doses of pemvidutide resulted in robust reductions in cardio-inflammatory, hepato-inflammatory and atherosclerotic lipids Findings support the potential benefit […]
BOSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the […]
WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), en ledende global leverandør av ingrediensløsninger til bruk […]
WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), der er en førende global leverandør af ingrediensløsninger […]